These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2339364)

  • 41. [Purification of antithrombin III by affinity chromatography in heparin-Trisacryl].
    Allary M; Boschetti E; Majurel M; Girot P; Saint-Blancard J
    Ann Pharm Fr; 1986; 44(5):379-86. PubMed ID: 3579161
    [No Abstract]   [Full Text] [Related]  

  • 42. Affinity high-performance liquid chromatography on heparin-Glc-Spheron.
    Dyr JE; Suttnar J
    J Chromatogr; 1991 Jan; 563(1):124-8. PubMed ID: 2061378
    [No Abstract]   [Full Text] [Related]  

  • 43. Amino acid sequence of porcine antithrombin III.
    Tokunaga F; Goto T; Wakabayashi S; Koide T
    J Biochem; 1994 Nov; 116(5):1164-70. PubMed ID: 7896748
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical and biochemical characterization of antithrombin III Franconville, a variant with Pro 41 Leu mutation.
    de Roux N; Chadeuf G; Molho-Sabatier P; Plouin PF; Aiach M
    Br J Haematol; 1990 Jun; 75(2):222-7. PubMed ID: 2372510
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pasteurisation induced changes in an antithrombin III concentrate.
    Winkelman L; Haddon ME
    Thromb Res; 1986 Jul; 43(2):219-27. PubMed ID: 3738862
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antithrombin Glasgow, 393 Arg to His: a P1 reactive site variant with increased heparin affinity but no thrombin inhibitory activity.
    Owen MC; Beresford CH; Carrell RW
    FEBS Lett; 1988 Apr; 231(2):317-20. PubMed ID: 3360140
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of a new potent heparin. 5th Communication: Further characterization by affinity chromatography on antithrombin-sepharose and its comparison with a commercially available heparin.
    Bhargava AS; Freihube G; Günzel P
    Arzneimittelforschung; 1980; 30(10):1621-3. PubMed ID: 7192096
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Purification and characterization of hereditary abnormal antithrombin III with impaired thrombin binding.
    Jørgensen M; Petersen LC; Thorsen S
    J Lab Clin Med; 1984 Aug; 104(2):245-56. PubMed ID: 6747440
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Separation by heparin-affinity chromatography of catalytically active and inactive forms of trypsin which retain the (Na-K)ATPase stimulating property.
    Finotti P
    Clin Chim Acta; 1996 Dec; 256(1):37-51. PubMed ID: 8960786
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Heparin cofactor II: purification and antibody production.
    Tran TH; Lämmle B; Zbinden B; Duckert F
    Thromb Haemost; 1986 Feb; 55(1):19-23. PubMed ID: 3518132
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of different ions on the interactions of heparin with bovine antithrombin III and thrombin.
    Oshima G; Nagasawa K
    Thromb Res; 1986 May; 42(3):375-82. PubMed ID: 3715809
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antithrombin-III assay without influence of heparin cofactor II.
    Enomoto M; Tanimizu I; Sakuragawa N
    Thromb Res; 1990 Mar; 57(5):729-36. PubMed ID: 2339367
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recovery of antithrombin III from milk by expanded bed chromatography.
    Ozyurt S; Kirdar B; Ulgen KO
    J Chromatogr A; 2002 Jan; 944(1-2):203-10. PubMed ID: 11831754
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression of functionally active human antithrombin III.
    Stephens AW; Siddiqui A; Hirs CH
    Proc Natl Acad Sci U S A; 1987 Jun; 84(11):3886-90. PubMed ID: 3473488
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Purification of antithrombin 'Vicenza': a molecule with normal heparin affinity and impaired reactivity to thrombin.
    Finazzi G; Tran TH; Barbui T; Duckert F
    Br J Haematol; 1985 Feb; 59(2):259-63. PubMed ID: 3970857
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Affinity chromatography of embryonic inducing factors on heparin-Sepharose.
    Born J; Davids M; Tiedemann H
    Cell Differ; 1987 Jul; 21(2):131-6. PubMed ID: 3652212
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interaction of antithrombin III with surface-immobilized albumin-heparin conjugates.
    van Delden CJ; Engbers GH; Feijen J
    J Biomed Mater Res; 1995 Nov; 29(11):1317-29. PubMed ID: 8582900
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Novel purification of vitronectin from human plasma by heparin affinity chromatography.
    Yatohgo T; Izumi M; Kashiwagi H; Hayashi M
    Cell Struct Funct; 1988 Aug; 13(4):281-92. PubMed ID: 2460263
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anticoagulant properties of heparin preparations from different animal sources with equivalent high affinity for antithrombin III.
    Nagasawa K; Uchiyama H
    J Biochem; 1984 Mar; 95(3):619-26. PubMed ID: 6725227
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ability of high-affinity heparin fractions with decreasing affinity for antithrombin III to activate ATIII isoforms.
    Carlson TH; Kolman MR; Frees A; Babcock T
    Thromb Res; 1990 Aug; 59(3):521-30. PubMed ID: 2237824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.